Table 2. CRS and ICANS grades at... | American Society of Hematology

Table 2.

CRS and ICANS grades at siltuximab administration

	Treatment naïve∗		Patients with prior treatment†
	n	%	n	%
CRS grade
1	6	21	4	25
2	22	79	7	44
3	0	0	3	19
4	0	0	2	12
ICANS grade
1	5	38	0	0
2	6	46	1	6
3	2	15	8	47
4	0	0	8	47

	Treatment naïve∗		Patients with prior treatment†
	n	%	n	%
CRS grade
1	6	21	4	25
2	22	79	7	44
3	0	0	3	19
4	0	0	2	12
ICANS grade
1	5	38	0	0
2	6	46	1	6
3	2	15	8	47
4	0	0	8	47

Patients who did not receive tocilizumab for CRS or steroids for ICANS before treatment with siltuximab.

Patients who received tocilizumab and/or steroids before treatment with siltuximab.